Our Research
Through our thought leadership efforts, we inform and influence policy outcomes to ultimately improve access to healthcare and enhance societal wellbeing. Our professionals regularly author and publish peer-reviewed articles, research reports, commentaries, opinion pieces, and whitepapers.
Recent Peer-Reviewed Articles:
October 2024 - Journal of Medical Economics:
Transcatheter aortic valve replacement and the value of increasing treatment for severe symptomatic aortic stenosis: a plain language summary [Read More]
September 2024 - BMJ Global Health:
The global health and economic value of COVID-19 vaccination [Read More]
December 2023 - Journal of Medical Economics:
COVID-19 vaccines should be evaluated from the societal perspective [Read More]
September 2022 - Current Opinion in Immunology:
The value of vaccines [Read More]
August 2022 - Journal of Medical Economics:
Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient population [Read More]
March 2022 - Journal of Economic Literature: Modern Infectious Diseases:
Macroeconomic impacts and policy responses [Read More]
December 2021 -Finance & Development, International Monetary Fund:
Dementia storm on the horizon [Read More]
February 2021 - Health Affairs:
How new models of vaccine development for COVID-19 have helped address an epic public health crisis [Read More]
July 2019 - The Journal of the Economics of Ageing:
Indirect costs of adult pneumococcal disease and productivity-based rate of return to PCV13 vaccination for older adults and elderly diabetics in Denmark [Read More]
September 2024 - Journal of Benefit-Cost Analysis:
The Health-Augmented Lifecycle Model [Read More]
January 2024 - The European Journal of Health Economics
Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK [Read More]
August 2023 - Journal of Medical Economics:
Immunization, not vaccination: monoclonal antibodies for infant RSV prevention and the US vaccines for children program [Read More]
September 2022 – Human Vaccines & Immunotherapeutics:
Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt [Read More]
July 2022 - Lancet:
Global and regional projections of the economic burden of Alzheimer’s disease and related dementias from 2019 to 2050: A value of statistical life approach [Read More]
January 2022 - PLoS Neglected Tropical Diseases:
Community trust of government and non-governmental organizations during the 2014-2016 Ebola epidemic in Liberia [Read More]
February 2021 - PLoS Computational Biology:
Adaptive social contact rates induce complex dynamics during epidemics [Read More]
July 2019 - Human Vaccines & Immunotherapeutics:
Indirect costs of adult pneumococcal disease and productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey [Read More]
Other Recent Papers:
April 2024 - Landslide, American Bar Association
Bringing Experimentation to Intellectual Property Litigation [Read More]
April 2022 – Prioritarianism in Practice:
Chapter 12: Prioritarianism and the COVID-19 pandemic [Read More]
June 2021 - Des Moines Register:
To prosper, let's not lose our determination for vaccination after the pandemic ends [Read More]
March 2020:
COVID-19 and the economic impacts of working from home [Read More]
November 2022 - VOX-EU:
Healthy ageing for a healthy economy [Read More]
February 2022 - World Economic Forum:
How to address Alzheimer's disease and support healthier aging [Read More]
August 2021 – VOX-EU:
Alternative value frameworks for assessing COVID-19 pandemic policies [Read More]
February 2021:
Women's work, wages, and wellbeing in the time of COVID-19 [Read More]